Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) Director Derrell Porter sold 13,040 shares of Acumen Pharmaceuticals stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $2.33, for a total transaction of $30,383.20. Following the transaction, the director directly owned 35,500 shares of the company’s stock, valued […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director William Phd Link sold 12,500 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $62.12, for a total transaction of $776,500.00. Following the completion of the transaction, the director owned 106,786 shares in the […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Holly Kordasiewicz sold 60,846 shares of Ionis Pharmaceuticals stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $73.41, for a total value of $4,466,704.86. Following the completion of the transaction, the executive vice president owned 22,458 shares of […]

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) VP Meredith Cook sold 500 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $82.03, for a total transaction of $41,015.00. Following the transaction, the vice president directly owned 77,890 shares in the […]

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Alexander Fitzpatrick sold 3,355 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $10.00, for a total transaction of $33,550.00. Following the completion of the transaction, the insider owned 90,910 shares of the […]

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) EVP Neena Patil sold 1,200 shares of the stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $231.83, for a total transaction of $278,196.00. Following the sale, the executive vice president directly owned 51,549 shares in the company, valued […]

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director John Lamattina sold 4,591 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $250.88, for a total transaction of $1,151,790.08. Following the sale, the director directly owned 26,969 shares in the company, […]

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) Director Anne Altmeyer sold 2,412 shares of Corbus Pharmaceuticals stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $7.91, for a total transaction of $19,078.92. Following the completion of the transaction, the director directly owned 7,579 […]

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) Director Gary Patou sold 1,322 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $53.14, for a total value of $70,251.08. Following the completion of the transaction, the director directly owned 24,896 shares […]

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director David Pyott sold 3,830 shares of Alnylam Pharmaceuticals stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $299.18, for a total value of $1,145,859.40. Following the sale, the director directly owned 1,582 shares in the company, valued at […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) Director Spencer Berthelsen sold 8,000 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $75.67, for a total value of $605,360.00. Following the transaction, the director owned 156,013 shares in the company, valued at $11,805,503.71. […]